Galileo Life Sciences, a Subsidiary of Modern Mobility Aids Inc (MDRM) Announces Expanded Leadership to Drive Next Highly Ant...
01 February 2021 - 11:00PM
InvestorsHub NewsWire
New Additions to Leadership Include Gilbert Sharpe as
Director of Health Care, Ahmed Abdalla as Vice President of
Business Development, and Others in Various Key
Roles
TORONTO, ONTARIO, CANADA -- February 1,
2021 -- InvestorsHub NewsWire -- Galileo Life Sciences
Inc, (Galileo, the “Company”) a subsidiary of Modern Mobility
Aids, Inc. (OTC
Pink - MDRM) announced today that its Board of Directors
appointed Gilbert Sharpe Director of Health Care. Gilbert, former
long-time Director of the Legal Branch of the Ontario Ministry of
Health and Long-Term Care brings to Galileo Life Sciences over 40
years of experience in advisory, law, and private practice. The
Company also announced its appointment of Ahmed Abdalla as Vice
President of Business Development, Mikhael Kushevsky as Chief
Technology Officer, and Carlos Saldana as Vice President of
Marketing in the region of Latin
America.
About Gilbert
Sharpe
Gilbert Sharpe brings invaluable experience from a
distinguished 40-year career in legal practice and advisory roles.
Following 15 years in private practice as a partner at several
major Bay Street law firms, he currently operates a boutique
healthcare advisory service. Gilbert offers unparalleled experience
in healthcare public policy and regulation and intimately
understands the complex realm of evolving public and private
healthcare dynamics in
Canada.
“Given our vision of revolutionizing the way
healthcare is delivered, we have decided to make several new
additions to leadership, fitting in line with our current
high-growth focus. We are thrilled to introduce Gilbert Sharpe as
Director of Health Care of Galileo Life Sciences. Through Gilbert’s
involvement with the Ministry of Health since 1975 and work with
numerous government ministries and agencies, he has influenced some
of the more crucial legal decisions and policy matters affecting
modern health care. He is an invaluable new asset to the company,
whose vision, determination, and experience will lead us on the
road to achieving our planned objectives.” stated Tito DiMarco,
President of the Company
Parallel to his aforementioned achievements, Gilbert
has acted as Editor-In-Chief of the leading health law journal,
“Health Law in Canada” for over 40 years, founded the first
Canadian health law courses at Osgoode Hall Law School, Dalhousie,
and the University of Ottawa, and authored hundreds of published
articles and texts, including “Doctors and the Law” and “The Law
and Medicine in Canada.”
About Mickhael
Kushevsky
Mikhael Kushevsky, appointed Chief Technology
Officer, is a fintech entrepreneur executive with startup and
corporate expertise implementing mobile, ecommerce, prepaid, Apple
Pay, EMV, NKC, digital wallet, and blockchain solutions. In
addition to co-founding Marbles Corp, a blockchain cryptocurrency
game and a Smart Wallet tied with Crypto-Fiat exchange, he formed
XRomb Inc. to build a mobile commerce platform with NFC cloud
mobile wallets, coupon, loyalty, and e-commerce technologies.
Following, he co-founded Credorax Inc, a global merchant Acquiring
Bank and merchant processors. Throughout the 20+ years he has been
in the field, he has also created several social commerce
applications and websites featuring some of the most popular
consumer products and stores in the
world.
About Carlos
Saldana
Carlos Saldana, appointed Vice President of Marketing
for the region of Latin America, brings to the company 20 years of
business development experience centralized in South America. He
has experience with startups, international licensing agreements,
and has co-founded two successful entities, including Berkana SAS
and Pacifica PMO SAS – both based in
Colombia.
“Upon seeing the effects of the COVID-19 pandemic, we
are looking ahead to bring significant positive change to the Latin
American telemedicine market as well as our home market. The last
year has shown us that telemedicine provides a remarkable
opportunity for the average person to access health services where
they otherwise would simply not be able to,” says Tito DiMarco,
President of Modern Mobility Aids. “I am pleased to welcome Carlos to our team, where
he will support the marketing side in a region where telemedicine
is to see a very notable increase in popularity in the coming
years, allowing access to medicine for the
majority.”
About Ahmed
Abdalla
Ahmed Abdalla, appointed Vice President of Business
Development, brings 25 years of experience spearheading successful
startup companies and those in early but rigorous stages of
development. Ahmed’s key leadership moments to date include
yielding $15 million in revenue throughout his time of ownership
and operations of Richtell Communications (Toronto), acting as
Partner at a renowned brokerage firm in Amman, Jordan (2005-2015),
and more.
Forward-looking
Statements
This press release may contain information that may
constitute “forward-looking information” or “forward-looking
statements” within the meaning of applicable Canadian
and U.S. securities laws (collectively, “Forward-looking
Statements”). All information contained herein that is not clearly
historical in nature may constitute Forward-looking Statements. In
some cases, Forward-looking Statements can be identified by the use
of forward-looking terminology such as “may”, “will”, “expect”,
“plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe”
or the negative of these terms, or other similar expressions
intended to identify Forward-looking
Statements. There are no guarantees or assurances that expansion
in leadership will result in the hopes the company has mentioned
here. Any investment made into Modern Mobility Aids, Inc., would be
classified as speculative and risky. Such risks and uncertainties
include, but are not limited to, market conditions, general
acceptance of the company’s products and technologies, competitive
factors, the ability to successfully complete additional or
adequate financing, government approvals or changes to proposed
laws and other risks and uncertainties further stated in the
company’s financial reports and filings.
Any
Forward-looking Statement included in this press release is made as
of the date of this press release and, except as required by
law, Galileo Life Sciences Inc. and Modern Mobility Aids
Inc. disclaim any obligation to update or revise any
Forward-looking Statement. Readers are cautioned not to put undue
reliance on any Forward-looking
Statement.
Modern Mobility
Aids is listed on the New York OTC Pink Market and currently trades
under the ticker symbol
MDRM.
For more information, please
visit our new website at: www.galileolife.com and www.mrdminc.com or
contact:
Tito
DiMarco
President,
Modern Mobility
Aids Inc.
tdimarco@mdrminc.com
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Nov 2023 to Nov 2024